Nazemian, Ryan
Matta, Maroun
Aldamouk, Amer
Zhu, Lin
Awad, Mohamed
Pophal, Megan
Palmer, Nicole R.
Armes, Tonya
Hausladen, Alfred
Stamler, Jonathan S.
Reynolds, James D.
Funding for this research was provided by:
Roche Organ Transplant Research Foundation (Grant #61800655)
AHA-Allen Brain Health Initiative (19PABHI34580006)
Eppley Foundation
US Army Medical Research and Materiel Command (W81XWH-16-1-0520)
Enduring Hearts
Additional Ventures
Article History
Received: 25 June 2021
Accepted: 9 March 2022
First Online: 22 April 2022
Competing interests
: Drs. Stamler and Reynolds hold patents related to renitrosylation, some of which may be licensed for commercial development. In addition, Dr. Stamler has an equity interest in SNO Bio, a company developing nitrosylation related therapeutics. Their institutions are aware of these potential conflicts and appropriate management plans are in place. None of the other authors have relevant conflicts to disclose.